Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Stock indices matter because they summarize broad market performance, guide diversification, and influence risk assessments for investors.
27,507 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Apple readies its largest AI push at WWDC, centering on Siri and the iPhone as an AI gateway. The move could reshape ...
CleanSpark stock surged after disclosing a $6.6 billion, 20-year data center lease in Georgia, underscoring a shift f...
Meta unveils its MTIA 300 AI inference chip, signaling a move to in-house AI deployment that could alter ROI dynamics...
Broadcom posted a robust Q2 with AI-driven revenue rising sharply, but the stock pulled back. A bold market thesis, h...
Lucid shares rebound for a second day after the CEO refutes bankruptcy and take-private rumors, with investors eyeing...
Cleo Capital urges investors to recalibrate Nvidia's growth outlook as AI infrastructure spending moves from explosiv...
GameStop posts a strong Q1 FY26 beat and authorizes a $2 billion buyback, signaling a pivot to a cash-rich model. The...
Sunway Healthcare opened sharply higher on its first trading day after a multi-billion ringgit IPO, reflecting growin...
SpaceX is set to debut on the public market tomorrow after planning a record-breaking raise, drawing unprecedented in...
Airbnb posts a solid Q4, prompting Truist to lift its target to $129 and move the stock to Hold. The shift signals a ...
Micron Technology has delivered a stunning 770% year-to-date surge as AI-driven memory demand intensifies. The rally ...